Oncotarget, the online news source for cancer researchers and doctors in the filed of oncology, has been instrumental in presenting the medical field with the latest positive news articles and research papers in this difficult field. Oncotarget presented articles endeavoring to explain new therapies for a particularly malignant form of thyroid cancer, with the result that a team of researchers and doctors were able to apply a new therapy and technique for this particular malignancy. By simply addressing the issues and the results of tests and procedures as described in this online journal, new pathways were discovered that rendered some of the other methods of information transmission entirely secondary. This was a momentous occasion for Oncotarget and for the World Wide Web as well. Check the journal at SCImago Journal & Country Rank.
This information brings Oncotarget to the fore as one of the most effective forms of communication presentations among researchers today. No other online journal has ever replicated these types of results among subscribers. Follow Oncotarget journal on Twitter.
As an online journal of cancer research and news, Oncotarget is presented by Impact journals as a biweekly (twice per week) journal exploring the world of cancer research and medical techniques. From time to time, Oncotarget presents articles of interest in other medical fields as well. Led by two Russian doctors and researchers as editors-in-chief, Oncotarget has been successfully published since 2010, and is one of the most widely researched and read journals in ontological research today. Oncotarget is thus in the forefront of medical research today. Its place in the world of medical research and literature is assured.